New York, NY -- (SBWire) -- 07/01/2022 --Back in 2021, AstraZeneca bought Alexion Pharma in a $39 billion deal that was something of a landmark in the industry. It was thought that this acquisition would trigger all kinds of antitrust issues, especially in the light of a threatened renewal in antitrust scrutiny, and yet the deal sailed through in April last year. Now, all of the blood, sweat and tears that must have gone into making that deal happen have all proven to be worth it as the purchase of the Boston biotech hub really starts to pay off for AstraZeneca. That's because the first and only long-acting C5 complement inhibitor in gMG, Ultomiris (ravulizumab-cwvz) has gained approval in the US. Due to the purchase of Alexion by AstraZeneca last year that makes AstraZeneca the owner of the approved inhibitor. Following the successful acquisition last year, a new division was set up in the company and it's thought that this has been the driving force behind the approval.
EPM Scientific is a biotech recruiter supporting innovative firms like AstraZeneca in building teams that enable this kind of innovation to take place. The firm was established in 2012 and has nurtured a wealth of insight and knowledge as a biotech recruiter, as well as valuable networks. The team works in many different areas of life sciences recruitment, including legal and compliance, medical affairs, quality, medical communications and clinical development. This more holistic approach to hiring means the team at EPM Scientific is so much more than just a biotech recruiter, with expertise across the whole life sciences industry. Thanks to extensive resources EPM Scientific has been able to support a broad range of different businesses, from innovative startups to global megabrands. Those resources include a database of more than a million mid-to-senior professionals and a versatile mix of permanent, contract and multi-hire solutions that can be managed to create bespoke options for every hiring need.
Part of building a robust network as a biotech recruiter in the US has been establishing nationwide reach. This coverage includes most major cities, including New York, Chicago, Boston, Dallas, Charlotte, Los Angeles and San Francisco, and many other locations in between. Plus, EPM Scientific has the advantage of a robust international network that is the result of the US team being integrated into a 1,000+ strong worldwide workforce. Not only that but the firm is the recruitment partner of choice to hundreds of world-leading companies as part of the Phaidon International group, which operates across 6 countries. Talent is critical in the life sciences industry and this is something the EPM Scientific appreciates as a biotech recruiter. The right people can make all the difference when it comes to innovation and growth. As a result, the firm invests consistently in its own people - consultants are trained on an ongoing basis and work with best-in-class recruitment technology and strategies. As a biotech recruiter with a broad range of life sciences experience, EPM Scientific is able to offer many different roles, including QC Analyst, Cleaning Validation Specialist and Director, Rare Disease Marketing.
Alec Rahman-Jones, Managing Director at EPM Scientific, comments, "Life Sciences organizations and professionals will play a critical role in protecting public health in 2022, putting more pressure on companies to have the right staff in place." He continues, "EPM Scientific is working with a range of industry leading clients from large pharmaceutical companies to innovative biotech's, ensuring that our clients are able to attract and secure top professionals. Our team can support these clients across the full lifecycle of production from R&D and development, to commercial, quality, and regulation."
To find out more about Biotech recruiter visit https://www.epmscientific.com.
For any media inquiries please contact Gary Elliott at Iconic Digital – 020 7100 0726.
For all other inquiries please contact EPM Scientific USA: +1 646 759 4560.
For more information about EPM Scientific services, please go to https://www.epmscientific.com.
About EPM Scientific USA
EPM Scientific USA partners with organizations across the fast-expanding pharmacovigilance sector. The firm's 1000+ employees support growth and development among enterprises where innovation and insight will be crucial to both current and future generations.
Boston Biotech Hub Purchase Starts to Pay off for AstraZeneca